Publications
-
Increased fluid intake does not augment capacity to lay down new collagen in nursing home residents at risk for pressure ulcers: a randomized, controlled clinical trial.
Stotts NA,
Hopf HW, Kayser-Jones J, Chertow GM, Cooper BA, Wu HS.
Wound Repair Regen.
2009 Nov-Dec;
17
(6):
780-8
-
Medication errors in chronic kidney disease: one piece in the patient safety puzzle.
Fink JC,
Chertow GM.
Kidney Int.
2009;
76
(11):
1123-5
-
Melamine nephrotoxicity: an emerging epidemic in an era of globalization.
Bhalla V,
Grimm PC, Chertow GM, Pao AC.
Kidney Int.
2009;
75
(8):
774-9
-
Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury.
Bouchard J,
Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL.
Kidney Int.
2009;
76
(4):
422-7
-
Dialysis: Phosphorus binders and survival: need for randomized trials.
Ix JH,
Chertow GM.
Nat Rev Nephrol.
2009;
5
(7):
368-70
-
Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey.
Wilhelm-Leen ER,
Hall YN, Tamura MK, Chertow GM.
Am J Med.
2009;
122
(7):
664-71.e2
-
The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: a systematic review.
Desai AA,
Nissenson A, Chertow GM, Farid M, Singh I, Van Oijen MG, Esrailian E, Solomon MD, Spiegel BM.
Hemodial Int.
2009;
13
(3):
347-59
-
A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: a new paradigm for clinical outcomes studies in nephrology.
Block GA,
Persky MS, Ketteler M, Kestenbaum B, Thadhani R, Kooienga L, Spiegel D, Asplin J, Ehrlich J, Dennis V, Nissenson A, Chertow GM, Wheeler DC.
Hemodial Int.
2009;
13
(3):
360-2
-
Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease.
Lo LJ,
Go AS, Chertow GM, McCulloch CE, Fan D, Ordoņez JD, Hsu CY.
Kidney Int.
2009;
76
(8):
893-9
-
Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury.
Bouchard J,
Macedo E, Soroko S, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL.
Nephrol Dial Transplant.
2009
-
Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study.
Palevsky PM,
O'Connor TZ, Chertow GM, Crowley ST, Zhang JH, Kellum JA.
Crit Care.
2009;
13
(4):
310
-
Fetuin-A and change in body composition in older persons.
Ix JH,
Wassel CL, Chertow GM, Koster A, Johnson KC, Tylavsky FA, Cauley JA, Cummings SR, Harris TB, Shlipak MG.
J Clin Endocrinol Metab.
2009;
94
(11):
4492-8
-
Choroidopathy and kidney disease: a case report and review of the literature.
Kamdar NV,
Erko A, Ehrlich JS, Kim JW, Kambham N, Chertow GM.
Cases J.
2009:
2
7425
-
Functional status of elderly adults before and after initiation of dialysis.
Kurella Tamura M,
Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE.
N Engl J Med.
2009;
361
(16):
1539-47
-
An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard.
Lee CP,
Chertow GM, Zenios SA.
Value Health.
2009;
12
(1):
80-7
-
Regional variation in kidney transplant outcomes: trends over time.
Chakkera HA,
Chertow GM, O'Hare AM, Amend WJ, Gonwa TA.
Clin J Am Soc Nephrol.
2009;
4
(1):
152-9
-
Cautious optimism concerning long-term safety of kidney donation.
Tan JC,
Chertow GM.
N Engl J Med.
2009;
360
(5):
522-3
-
Surface-area-normalized Kt/V: a method of rescaling dialysis dose to body surface area-implications for different-size patients by gender.
Daugirdas JT,
Depner TA, Greene T, Kuhlmann MK, Levin NW, Chertow GM, Rocco MV.
Semin Dial.
2008 Sep-Oct;
21
(5):
415-21
-
Comparison of proposed alternative methods for rescaling dialysis dose: resting energy expenditure, high metabolic rate organ mass, liver size, and body surface area.
Daugirdas JT,
Levin NW, Kotanko P, Depner TA, Kuhlmann MK, Chertow GM, Rocco MV.
Semin Dial.
2008 Sep-Oct;
21
(5):
377-84
-
Toward the promise of renal replacement therapy.
Chertow GM,
Waikar SS.
J Am Soc Nephrol.
2008;
19
(5):
839-40
-
Lessons for successful study enrollment from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study.
Crowley ST,
Chertow GM, Vitale J, O'Connor T, Zhang J, Schein RM, Choudhury D, Finkel K, Vijayan A, Paganini E, Palevsky PM.
Clin J Am Soc Nephrol.
2008;
3
(4):
955-61
-
Higher serum creatinine concentrations in black patients with chronic kidney disease: beyond nutritional status and body composition.
Hsu J,
Johansen KL, Hsu CY, Kaysen GA, Chertow GM.
Clin J Am Soc Nephrol.
2008;
3
(4):
992-7
-
Trends and outcomes associated with serum albumin concentration among incident dialysis patients in the United States.
Kaysen GA,
Johansen KL, Cheng SC, Jin C, Chertow GM.
J Ren Nutr.
2008;
18
(4):
323-31
-
Cost-effectiveness of frequent in-center hemodialysis.
Lee CP,
Zenios SA, Chertow GM.
J Am Soc Nephrol.
2008;
19
(9):
1792-7
-
High-molecular weight iron dextran: a wolf in sheep's clothing?
Rodgers GM,
Auerbach M, Cella D, Chertow GM, Coyne DW, Glaspy JA, Henry DH.
J Am Soc Nephrol.
2008;
19
(5):
833-4
-
Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.
Deo R,
Fyr CL, Fried LF, Newman AB, Harris TB, Angleman S, Green C, Kritchevsky SB, Chertow GM, Cummings SR, Shlipak MG.
Am Heart J.
2008;
155
(1):
62-8
-
Intensity of renal support in critically ill patients with acute kidney injury.
Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P.
N Engl J Med.
2008;
359
(1):
7-20
-
A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease.
Xie D,
Joffe MM, Brunelli SM, Beck G, Chertow GM, Fink JC, Greene T, Hsu CY, Kusek JW, Landis R, Lash J, Levey AS, O'Conner A, Ojo A, Rahman M, Townsend RR, Wang H, Feldman HI.
Clin J Am Soc Nephrol.
2008;
3
(5):
1332-8
-
Management of acute kidney injury in the intensive care unit: a cost-effectiveness analysis of daily vs alternate-day hemodialysis.
Desai AA,
Baras J, Berk BB, Nakajima A, Garber AM, Owens D, Chertow GM.
Arch Intern Med.
2008;
168
(16):
1761-7
-
Neighborhood poverty and kidney transplantation among US Asians and Pacific Islanders with end-stage renal disease.
Hall YN,
O'Hare AM, Young BA, Boyko EJ, Chertow GM.
Am J Transplant.
2008;
8
(11):
2402-9
-
The risk of acute renal failure in patients with chronic kidney disease.
Hsu CY,
Ordoņez JD, Chertow GM, Fan D, McCulloch CE, Go AS.
Kidney Int.
2008;
74
(1):
101-7
-
Diagnosis, epidemiology and outcomes of acute kidney injury.
Waikar SS,
Liu KD, Chertow GM.
Clin J Am Soc Nephrol.
2008;
3
(3):
844-61
-
Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism.
Block GA,
Zeig S, Sugihara J, Chertow GM, Chi EM, Turner SA, Bushinsky DA.
Nephrol Dial Transplant.
2008;
23
(7):
2311-8
-
Rise of pay for performance: implications for care of people with chronic kidney disease.
Desai AA,
Garber AM, Chertow GM.
Clin J Am Soc Nephrol.
2007;
2
(5):
1087-95
-
Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury.
Liu KD,
Glidden DV, Eisner MD, Parsons PE, Ware LB, Wheeler A, Korpak A, Thompson BT, Chertow GM, Matthay MA.
Crit Care Med.
2007;
35
(12):
2755-61
-
Significance of frailty among dialysis patients.
Johansen KL,
Chertow GM, Jin C, Kutner NG.
J Am Soc Nephrol.
2007;
18
(11):
2960-7
-
Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients.
Johansen KL,
Chertow GM.
J Ren Nutr.
2007;
17
(5):
305-13
-
Community-based incidence of acute renal failure.
Hsu CY,
McCulloch CE, Fan D, Ordoņez JD, Chertow GM, Go AS.
Kidney Int.
2007;
72
(2):
208-12
-
Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study.
Ix JH,
Chertow GM, Shlipak MG, Brandenburg VM, Ketteler M, Whooley MA.
Circulation.
2007;
115
(19):
2533-9
-
Race and mortality after acute renal failure.
Waikar SS,
Curhan GC, Ayanian JZ, Chertow GM.
J Am Soc Nephrol.
2007;
18
(10):
2740-8
-
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.
Ix JH,
Shlipak MG, Chertow GM, Whooley MA.
Circulation.
2007;
115
(2):
173-9
-
Kidney function as a predictor of loss of lean mass in older adults: health, aging and body composition study.
Fried LF,
Boudreau R, Lee JS, Chertow G, Kurella-Tamura M, Shlipak MG, Ding J, Sellmeyer D, Tylavsky FA, Simsonick E, Kritchevsky SB, Harris TB, Newman AB.
J Am Geriatr Soc.
2007;
55
(10):
1578-84
-
Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview.
Chertow GM,
Pupim LB, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, London GM, Mahaffey KW, Moe SM, Wheeler DC, Albizem M, Olson K, Klassen P, Parfrey P.
Clin J Am Soc Nephrol.
2007;
2
(5):
898-905
-
The incidence and prognostic significance of acute kidney injury.
Waikar SS,
Liu KD, Chertow GM.
Curr Opin Nephrol Hypertens.
2007;
16
(3):
227-36
-
Phosphorus balance and mineral metabolism with 3 h daily hemodialysis.
Ayus JC,
Achinger SG, Mizani MR, Chertow GM, Furmaga W, Lee S, Rodriguez F.
Kidney Int.
2007;
71
(4):
336-42
-
Frequent Hemodialysis Network (FHN) randomized trials: study design.
Suri RS,
Garg AX, Chertow GM, Levin NW, Rocco MV, Greene T, Beck GJ, Gassman JJ, Eggers PW, Star RA, Ornt DB, Kliger AS.
Kidney Int.
2007;
71
(4):
349-59
-
Octogenarians and nonagenarians starting dialysis in the United States.
Kurella M,
Covinsky KE, Collins AJ, Chertow GM.
Ann Intern Med.
2007;
146
(3):
177-83
-
A simulation model to estimate the cost and effectiveness of alternative dialysis initiation strategies.
Lee CP,
Chertow GM, Zenios SA.
Med Decis Making.
2006 Sep-Oct;
26
(5):
535-49
-
Strategies for successful patient oriented research: why did I (not) get funded?
Agarwal R,
Chertow GM, Mehta RL.
Clin J Am Soc Nephrol.
2006;
1
(2):
340-3
-
Timing of initiation of dialysis in critically ill patients with acute kidney injury.
Liu KD,
Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, Chertow GM.
Clin J Am Soc Nephrol.
2006;
1
(5):
915-9
-
Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified.
Ix JH,
Quarles LD, Chertow GM.
Nat Clin Pract Nephrol.
2006;
2
(6):
337-9
-
Mortality after acute renal failure: models for prognostic stratification and risk adjustment.
Chertow GM,
Soroko SH, Paganini EP, Cho KC, Himmelfarb J, Ikizler TA, Mehta RL.
Kidney Int.
2006;
70
(6):
1120-6
-
Renal function and heart failure risk in older black and white individuals: the Health, Aging, and Body Composition Study.
Bibbins-Domingo K,
Chertow GM, Fried LF, Odden MC, Newman AB, Kritchevsky SB, Harris TB, Satterfield S, Cummings SR, Shlipak MG.
Arch Intern Med.
2006;
166
(13):
1396-402
-
The tortoise and hare on hemodialysis: does slow and steady win the race?
Chertow GM,
Kurella M, Lowrie EG.
Kidney Int.
2006;
70
(1):
24-5
-
Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study.
Kurella M,
Mapes DL, Port FK, Chertow GM.
Nephrol Dial Transplant.
2006;
21
(9):
2543-8
-
Fetuin-A and kidney function in persons with coronary artery disease--data from the Heart and Soul Study.
Ix JH,
Chertow GM, Shlipak MG, Brandenburg VM, Ketteler M, Whooley MA.
Nephrol Dial Transplant.
2006;
21
(8):
2144-51
-
Association of body size with health status in patients beginning dialysis.
Johansen KL,
Kutner NG, Young B, Chertow GM.
Am J Clin Nutr.
2006;
83
(3):
543-9
-
Update on adverse drug events associated with parenteral iron.
Chertow GM,
Mason PD, Vaage-Nilsen O, Ahlmén J.
Nephrol Dial Transplant.
2006;
21
(2):
378-82
-
Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation.
Triponez F,
Kebebew E, Dosseh D, Duh QY, Hazzan M, Noel C, Chertow GM, Wambergue F, Fleury D, Lemaitre V, Proye CA, Clark OH.
Surgery.
2006;
140
(6):
990-7; discussion 997-9
-
Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study.
Ix JH,
Shlipak MG, Chertow GM, Ali S, Schiller NB, Whooley MA.
J Card Fail.
2006;
12
(8):
601-7
-
Cystatin C and measures of physical function in elderly adults: the Health, Aging, and Body Composition (HABC) Study.
Odden MC,
Chertow GM, Fried LF, Newman AB, Connelly S, Angleman S, Harris TB, Simonsick EM, Shlipak MG.
Am J Epidemiol.
2006;
164
(12):
1180-9
-
Survival by dialysis modality in critically ill patients with acute kidney injury.
Cho KC,
Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, Chertow GM.
J Am Soc Nephrol.
2006;
17
(11):
3132-8
-
Tesio catheter access for long-term maintenance hemodialysis.
Wang J,
LaBerge JM, Chertow GM, Kerlan RK, Wilson MW, Gordon RL.
Radiology.
2006;
241
(1):
284-90
-
End stage renal disease.
Hall YN,
Chertow GM.
Clin Evid.
2006;
(15):
1171-81
-
Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease.
Peralta CA,
Shlipak MG, Fan D, Ordoņez J, Lash JP, Chertow GM, Go AS.
J Am Soc Nephrol.
2006;
17
(10):
2892-9
-
Lessons for Medicare Part D in the hemodialysis community.
Nayeem AI,
Chertow GM.
BMC Nephrol.
2006:
7
11
-
The metabolic syndrome and chronic kidney disease.
Peralta CA,
Kurella M, Lo JC, Chertow GM.
Curr Opin Nephrol Hypertens.
2006;
15
(4):
361-5
-
The enlarging body of evidence: obesity and chronic kidney disease.
Chertow GM,
Hsu CY, Johansen KL.
J Am Soc Nephrol.
2006;
17
(6):
1501-2
-
Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure.
Waikar SS,
Wald R, Chertow GM, Curhan GC, Winkelmayer WC, Liangos O, Sosa MA, Jaber BL.
J Am Soc Nephrol.
2006;
17
(6):
1688-94
-
Acute renal failure after endovascular vs open repair of abdominal aortic aneurysm.
Wald R,
Waikar SS, Liangos O, Pereira BJ, Chertow GM, Jaber BL.
J Vasc Surg.
2006;
43
(3):
460-466; discussion 466
-
Declining mortality in patients with acute renal failure, 1988 to 2002.
Waikar SS,
Curhan GC, Wald R, McCarthy EP, Chertow GM.
J Am Soc Nephrol.
2006;
17
(4):
1143-50
-
Challenging the validity of the EPO index.
Kaysen GA,
Müller HG, Ding J, Chertow GM.
Am J Kidney Dis.
2006;
47
(1):
166
-
PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.
Danese MD,
Kim J, Doan QV, Dylan M, Griffiths R, Chertow GM.
Am J Kidney Dis.
2006;
47
(1):
149-56
-
Cystatin C and mortality risk in the elderly: the health, aging, and body composition study.
Shlipak MG,
Wassel Fyr CL, Chertow GM, Harris TB, Kritchevsky SB, Tylavsky FA, Satterfield S, Cummings SR, Newman AB, Fried LF.
J Am Soc Nephrol.
2006;
17
(1):
254-61
-
Evolving practices in critical care and potential implications for management of acute kidney injury.
Liu KD,
Matthay MA, Chertow GM.
Clin J Am Soc Nephrol.
2006;
1
(4):
869-73
-
The case against calcium-based phosphate binders.
Moe SM,
Chertow GM.
Clin J Am Soc Nephrol.
2006;
1
(4):
697-703
-
Studying the prevention of acute kidney injury: lessons from an 18th-century mathematician.
Chertow GM,
Palevsky PM, Greene T.
Clin J Am Soc Nephrol.
2006;
1
(5):
1124-7
-
Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate.
Chertow GM,
Blumenthal S, Turner S, Roppolo M, Stern L, Chi EM, Reed J.
Clin J Am Soc Nephrol.
2006;
1
(2):
305-12
-
Frequent hemodialysis and psychosocial function.
Kurella M,
Suri RS, Chertow GM.
Semin Dial.
2005 Mar-Apr;
18
(2):
132-6
-
Angiotensin receptor blockade and arterial compliance in chronic kidney disease: a pilot study.
Garg JP,
Ellis R, Elliott WJ, Hasabou N, Chua D, Chertow GM, Bakris GL.
Am J Nephrol.
2005 Jul-Aug;
25
(4):
393-9
-
Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients.
Chertow GM,
Goldstein-Fuchs DJ, Lazarus JM, Kaysen GA.
Kidney Int.
2005;
68
(6):
2794-800
-
Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.
Chertow GM,
Burdick E, Honour M, Bonventre JV, Bates DW.
J Am Soc Nephrol.
2005;
16
(11):
3365-70
-
Self-assessed sleep quality in chronic kidney disease.
Kurella M,
Luan J, Lash JP, Chertow GM.
Int Urol Nephrol.
2005;
37
(1):
159-65
-
Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study.
Kurella M,
Chertow GM, Fried LF, Cummings SR, Harris T, Simonsick E, Satterfield S, Ayonayon H, Yaffe K.
J Am Soc Nephrol.
2005;
16
(7):
2127-33
-
Dialysis session length ("t") as a determinant of the adequacy of dialysis.
Kurella M,
Chertow GM.
Semin Nephrol.
2005;
25
(2):
90-5
-
Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease.
Lo JC,
Chertow GM, Go AS, Hsu CY.
Kidney Int.
2005;
67
(3):
1047-52
-
Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial.
Garg JP,
Chasan-Taber S, Blair A, Plone M, Bommer J, Raggi P, Chertow GM.
Arthritis Rheum.
2005;
52
(1):
290-5
-
Health-related quality of life and estimates of utility in chronic kidney disease.
Gorodetskaya I,
Zenios S, McCulloch CE, Bostrom A, Hsu CY, Bindman AB, Go AS, Chertow GM.
Kidney Int.
2005;
68
(6):
2801-8
-
Differential mortality and transplantation rates among Asians and Pacific Islanders with ESRD.
Hall YN,
Sugihara JG, Go AS, Chertow GM.
J Am Soc Nephrol.
2005;
16
(12):
3711-20
-
Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the Hemodialysis (HEMO) Study.
Burrowes JD,
Larive B, Chertow GM, Cockram DB, Dwyer JT, Greene T, Kusek JW, Leung J, Rocco MV.
Nephrol Dial Transplant.
2005;
20
(12):
2765-74
-
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism.
Cunningham J,
Danese M, Olson K, Klassen P, Chertow GM.
Kidney Int.
2005;
68
(4):
1793-800
-
Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study?
Dwyer JT,
Larive B, Leung J, Rocco MV, Greene T, Burrowes J, Chertow GM, Cockram DB, Chumlea WC, Daugirdas J, Frydrych A, Kusek JW.
Kidney Int.
2005;
68
(4):
1766-76
-
End stage renal disease.
Hall Y,
Chertow G.
Clin Evid.
2005;
(13):
1048-59
-
Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates.
Kirtane AJ,
Leder DM, Waikar SS, Chertow GM, Ray KK, Pinto DS, Karmpaliotis D, Burger AJ, Murphy SA, Cannon CP, Braunwald E, Gibson CM.
J Am Coll Cardiol.
2005;
45
(11):
1781-6
-
Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults.
Kurella M,
Lo JC, Chertow GM.
J Am Soc Nephrol.
2005;
16
(7):
2134-40
-
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
Ferramosca E,
Burke S, Chasan-Taber S, Ratti C, Chertow GM, Raggi P.
Am Heart J.
2005;
149
(5):
820-5
-
Beyond Framingham: cardiovascular risk profiling in ESRD.
McClellan WM,
Chertow GM.
J Am Soc Nephrol.
2005;
16
(6):
1539-41
-
Control of hypertension in adults with chronic kidney disease in the United States.
Peralta CA,
Hicks LS, Chertow GM, Ayanian JZ, Vittinghoff E, Lin F, Shlipak MG.
Hypertension.
2005;
45
(6):
1119-24
-
Insulin resistance in critically ill patients with acute renal failure.
Basi S,
Pupim LB, Simmons EM, Sezer MT, Shyr Y, Freedman S, Chertow GM, Mehta RL, Paganini E, Himmelfarb J, Ikizler TA.
Am J Physiol Renal Physiol.
2005;
289
(2):
F259-64
-
Medicare ESRD prospective payment system: weighing the evidence.
Himmelfarb J,
Chertow GM.
J Am Soc Nephrol.
2005;
16
(5):
1164-5
-
Bone disease and bottle caps.
Tichy M,
Garg JP, Cho KC, Chertow GM.
J Ren Nutr.
2005;
15
(2):
257-9
-
Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.
Raggi P,
James G, Burke SK, Bommer J, Chasan-Taber S, Holzer H, Braun J, Chertow GM.
J Bone Miner Res.
2005;
20
(5):
764-72
-
Chronic kidney disease and cognitive impairment in menopausal women.
Kurella M,
Yaffe K, Shlipak MG, Wenger NK, Chertow GM.
Am J Kidney Dis.
2005;
45
(1):
66-76
-
Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl.
Moe SM,
Chertow GM, Coburn JW, Quarles LD, Goodman WG, Block GA, Drüeke TB, Cunningham J, Sherrard DJ, McCary LC, Olson KA, Turner SA, Martin KJ.
Kidney Int.
2005;
67
(2):
760-71
-
Suicide in the United States end-stage renal disease program.
Kurella M,
Kimmel PL, Young BS, Chertow GM.
J Am Soc Nephrol.
2005;
16
(3):
774-81
-
Calcification or classification?
Chertow GM,
Moe SM.
J Am Soc Nephrol.
2005;
16
(2):
293-5
-
Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs.
Chakkera HA,
O'Hare AM, Johansen KL, Hynes D, Stroupe K, Colin PM, Chertow GM.
J Am Soc Nephrol.
2005;
16
(1):
269-77
-
Diminishing significance of HLA matching in kidney transplantation.
Su X,
Zenios SA, Chakkera H, Milford EL, Chertow GM.
Am J Transplant.
2004;
4
(9):
1501-8
-
Incorporating recipient choice in kidney transplantation.
Su X,
Zenios SA, Chertow GM.
J Am Soc Nephrol.
2004;
15
(6):
1656-63
-
Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer.
Raggi P,
Bommer J, Chertow GM.
J Heart Valve Dis.
2004;
13
(1):
134-41
-
The influence of patient- and facility-specific factors on nutritional status and survival in hemodialysis.
Kaysen GA,
Müller HG, Young BS, Leng X, Chertow GM.
J Ren Nutr.
2004;
14
(2):
72-81
-
Plasma cytokine levels predict mortality in patients with acute renal failure.
Simmons EM,
Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, Paganini EP, Soroko S, Freedman S, Becker K, Spratt D, Shyr Y, Ikizler TA.
Kidney Int.
2004;
65
(4):
1357-65
-
Physical and sexual function in women with chronic kidney disease.
Kurella M,
Ireland C, Hlatky MA, Shlipak MG, Yaffe K, Hulley SB, Chertow GM.
Am J Kidney Dis.
2004;
43
(5):
868-76
-
Screening to prevent coronary events or screening to detect obstruction?
Raggi P,
Budoff MJ, Chertow GM.
Am J Kidney Dis.
2004;
43
(5):
940; author reply 940-1
-
Prevention of radiocontrast nephropathy: back to basics.
Chertow GM,
JAMA.
2004;
291
(19):
2376-7
-
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
Block GA,
Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM.
J Am Soc Nephrol.
2004;
15
(8):
2208-18
-
Vector length as a proxy for the adequacy of ultrafiltration in hemodialysis.
Pillon L,
Piccoli A, Lowrie EG, Lazarus JM, Chertow GM.
Kidney Int.
2004;
66
(3):
1266-71
-
Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis.
Ix JH,
McCulloch CE, Chertow GM.
Nephrol Dial Transplant.
2004;
19
(11):
2747-53
-
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
Go AS,
Chertow GM, Fan D, McCulloch CE, Hsu CY.
N Engl J Med.
2004;
351
(13):
1296-305
-
Spectrum of acute renal failure in the intensive care unit: the PICARD experience.
Mehta RL,
Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, Paganini EP, Chertow GM.
Kidney Int.
2004;
66
(4):
1613-21
-
Cognitive impairment in chronic kidney disease.
Kurella M,
Chertow GM, Luan J, Yaffe K.
J Am Geriatr Soc.
2004;
52
(11):
1863-9
-
Validation of the Kidney Disease Quality of Life (KDQOL) cognitive function subscale.
Kurella M,
Luan J, Yaffe K, Chertow GM.
Kidney Int.
2004;
66
(6):
2361-7
-
Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
Tokmakova MP,
Skali H, Kenchaiah S, Braunwald E, Rouleau JL, Packer M, Chertow GM, Moyé LA, Pfeffer MA, Solomon SD.
Circulation.
2004;
110
(24):
3667-73
-
A 43-year-old woman with chronic renal insufficiency.
Chertow GM,
JAMA.
2004;
291
(10):
1252-9
-
Determinants of progressive vascular calcification in haemodialysis patients.
Chertow GM,
Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK.
Nephrol Dial Transplant.
2004;
19
(6):
1489-96
-
On the relative safety of parenteral iron formulations.
Chertow GM,
Mason PD, Vaage-Nilsen O, Ahlmén J.
Nephrol Dial Transplant.
2004;
19
(6):
1571-5
-
Association of body size with outcomes among patients beginning dialysis.
Johansen KL,
Young B, Kaysen GA, Chertow GM.
Am J Clin Nutr.
2004;
80
(2):
324-32
-
"Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency.
Chertow GM,
Normand SL, McNeil BJ.
J Am Soc Nephrol.
2004;
15
(9):
2462-8
-
Race/ethnicity and disease severity in IgA nephropathy.
Hall YN,
Fuentes EF, Chertow GM, Olson JL.
BMC Nephrol.
2004:
5
10
-
The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients.
Chertow GM,
Raggi P, McCarthy JT, Schulman G, Silberzweig J, Kuhlik A, Goodman WG, Boulay A, Burke SK, Toto RD.
Am J Nephrol.
2003 Sep-Oct;
23
(5):
307-14
-
Beware the rising creatinine level.
Shlipak MG,
Chertow GC, Massie BM.
J Card Fail.
2003;
9
(1):
26-8
-
Anthropometrically estimated total body water volumes are larger than modeled urea volume in chronic hemodialysis patients: effects of age, race, and gender.
Daugirdas JT,
Greene T, Depner TA, Chumlea C, Rocco MJ, Chertow GM.
Kidney Int.
2003;
64
(3):
1108-19
-
Analgesia in patients with ESRD: a review of available evidence.
Kurella M,
Bennett WM, Chertow GM.
Am J Kidney Dis.
2003;
42
(2):
217-28
-
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods.
Feldman HI,
Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, Fink JC, Franklin-Becker ED, Go AS, Hamm LL, He J, Hostetter T, Hsu CY, Jamerson K, Joffe M, Kusek JW, Landis JR, Lash JP, Miller ER, Mohler ER, Muntner P, Ojo AO, Rahman M, Townsend RR, Wright JT.
J Am Soc Nephrol.
2003;
14
(7 Suppl 2):
S148-53
-
Reasons for non-enrollment in a cohort study of ARF: the Program to Improve Care in Acute Renal Disease (PICARD) experience and implications for a clinical trials network.
Chertow GM,
Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL.
Am J Kidney Dis.
2003;
42
(3):
507-12
-
Slowing the progression of vascular calcification in hemodialysis.
Chertow GM,
J Am Soc Nephrol.
2003;
14
(9 Suppl 4):
S310-4
-
In critically ill patients with acute renal failure, outcomes, not dollars, should drive modality choice.
Mehta RL,
Chertow GM.
Crit Care Med.
2003;
31
(2):
644-6
-
Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis.
Hung AM,
Chertow GM, Young BS, Carey S, Johansen KL.
Adv Ren Replace Ther.
2003;
10
(3):
232-40
-
Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients.
Johansen KL,
Kaysen GA, Young BS, Hung AM, da Silva M, Chertow GM.
Am J Clin Nutr.
2003;
77
(4):
842-6
-
Acute renal failure definitions and classification: time for change?
Mehta RL,
Chertow GM.
J Am Soc Nephrol.
2003;
14
(8):
2178-87
-
With bioimpedance spectroscopy, the errors get fat when the patients get slim.
Chertow GM,
JPEN J Parenter Enteral Nutr.
2002 Mar-Apr;
26
(2):
128-9
-
Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis.
Hung AM,
Chertow GM, Young BS, Carey S, Johansen KL.
J Ren Nutr.
2002;
12
(3):
170-6
-
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.
Chertow GM,
Burke SK, Raggi P.
Kidney Int.
2002;
62
(1):
245-52
-
Refining predictive models in critically ill patients with acute renal failure.
Mehta RL,
Pascual MT, Gruta CG, Zhuang S, Chertow GM.
J Am Soc Nephrol.
2002;
13
(5):
1350-7
-
Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?
Raggi P,
Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM.
J Am Coll Cardiol.
2002;
39
(4):
695-701
-
Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients.
Shlipak MG,
Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB.
Ann Intern Med.
2002;
137
(7):
555-62
-
Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency.
Hsu CY,
Chertow GM.
Nephrol Dial Transplant.
2002;
17
(8):
1419-25
-
Bone mineral density is not diminished by mild to moderate chronic renal insufficiency.
Hsu CY,
Cummings SR, McCulloch CE, Chertow GM.
Kidney Int.
2002;
61
(5):
1814-20
-
Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency.
Hsu CY,
Chertow GM, Curhan GC.
Kidney Int.
2002;
61
(5):
1567-76
-
Nephrology consultation in acute renal failure: does timing matter?
Mehta RL,
McDonald B, Gabbai F, Pahl M, Farkas A, Pascual MT, Zhuang S, Kaplan RM, Chertow GM.
Am J Med.
2002;
113
(6):
456-61
-
Diuretics, mortality, and nonrecovery of renal function in acute renal failure.
Mehta RL,
Pascual MT, Soroko S, Chertow GM.
JAMA.
2002;
288
(20):
2547-53
-
Renal insufficiency with monoclonal gammopathy and urticarial vasculitis.
O'Hare A,
Olson JL, Connolly MK, Ward JW, Stein P, Wisnieski JJ, Chertow GM.
Am J Kidney Dis.
2002;
39
(1):
203-7
-
The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease.
De Boer IH,
Gorodetskaya I, Young B, Hsu CY, Chertow GM.
J Am Soc Nephrol.
2002;
13
(11):
2762-9
-
Mechanisms underlying renoprotection during renin-angiotensin system blockade.
Taal MW,
Chertow GM, Rennke HG, Gurnani A, Jiang T, Shahsafaei A, Troy JL, Brenner BM, Mackenzie HS.
Am J Physiol Renal Physiol.
2001;
280
(2):
F343-55
-
Gridlock on the road to kidney transplantation.
Chertow G,
Zenios S.
Am J Kidney Dis.
2001;
37
(2):
435-7
-
Guided medication dosing for inpatients with renal insufficiency.
Chertow GM,
Lee J, Kuperman GJ, Burdick E, Horsky J, Seger DL, Lee R, Mekala A, Song J, Komaroff AL, Bates DW.
JAMA.
2001;
286
(22):
2839-44
-
Determinants of physical performance in ambulatory patients on hemodialysis.
Johansen KL,
Chertow GM, da Silva M, Carey S, Painter P.
Kidney Int.
2001;
60
(4):
1586-91
-
Cardiac arrest and sudden death in dialysis units.
Karnik JA,
Young BS, Lew NL, Herget M, Dubinsky C, Lazarus JM, Chertow GM.
Kidney Int.
2001;
60
(1):
350-7
-
Validation of questionnaires to estimate physical activity and functioning in end-stage renal disease.
Johansen KL,
Painter P, Kent-Braun JA, Ng AV, Carey S, Da Silva M, Chertow GM.
Kidney Int.
2001;
59
(3):
1121-7
-
"Wishing don't make it so"--why we need a randomized clinical trial of high-intensity hemodialysis.
Chertow GM,
J Am Soc Nephrol.
2001;
12
(12):
2850-3
-
Correlates of acute renal failure in patients receiving parenteral amphotericin B.
Bates DW,
Su L, Yu DT, Chertow GM, Seger DL, Gomes DR, Platt R.
Kidney Int.
2001;
60
(4):
1452-9
-
Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients.
Kaysen GA,
Chertow GM, Adhikarla R, Young B, Ronco C, Levin NW.
Kidney Int.
2001;
60
(1):
333-40
-
Suspected iron dextran-related adverse drug events in hemodialysis patients.
Fletes R,
Lazarus JM, Gage J, Chertow GM.
Am J Kidney Dis.
2001;
37
(4):
743-9
-
beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis.
Hou FF,
Miyata T, Boyce J, Yuan Q, Chertow GM, Kay J, Schmidt AM, Owen WF.
Kidney Int.
2001;
59
(3):
990-1002
-
Mortality and costs of acute renal failure associated with amphotericin B therapy.
Bates DW,
Su L, Yu DT, Chertow GM, Seger DL, Gomes DR, Dasbach EJ, Platt R.
Clin Infect Dis.
2001;
32
(5):
686-93
-
Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group.
Lewis J,
Salem MM, Chertow GM, Weisberg LS, McGrew F, Marbury TC, Allgren RL.
Am J Kidney Dis.
2000;
36
(4):
767-74
-
Acute renal failure with interstitial nephritis in a patient with AIDS.
Mouratoff JG,
Tokumoto J, Olson JL, Chertow GM.
Am J Kidney Dis.
2000;
35
(3):
557-61
-
Reply from the authors
Chertow GM,
Kidney Int.
2000;
58
(3):
1358-9
-
Chronic renal confusion: insufficiency, failure, dysfunction, or disease.
Hsu CY,
Chertow GM.
Am J Kidney Dis.
2000;
36
(2):
415-8
-
Sevelamer with and without calcium and vitamin D: observations from a long-term open-label clinical trial.
Chertow GM,
Dillon MA, Amin N, Burke SK.
J Ren Nutr.
2000;
10
(3):
125-32
-
Leveling the "paying" field in end-stage renal disease.
Chertow GM,
Am J Med.
2000;
108
(8):
666-8
-
Predicting acute renal failure after coronary bypass surgery: cross-validation of two risk-stratification algorithms.
Fortescue EB,
Bates DW, Chertow GM.
Kidney Int.
2000;
57
(6):
2594-602
-
Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients
Chertow GM,
Burke SK, Dillon MA, Slatopolsky E.
Nephrol Dial Transplant.
2000;
15
(4):
559
-
Renal nutrition in the new millennium.
Chertow GM,
J Ren Nutr.
2000;
10
(1):
1
-
Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients.
Chertow GM,
Ackert K, Lew NL, Lazarus JM, Lowrie EG.
Kidney Int.
2000;
58
(6):
2512-7
-
Crystalloids versus colloids for resuscitation in shock.
Waikar SS,
Chertow GM.
Curr Opin Nephrol Hypertens.
2000;
9
(5):
501-4
-
Ochrobactrum anthropi bacteremia in a patient on hemodialysis.
Chertow GM,
Am J Kidney Dis.
2000;
35
(6):
E30
-
Survival after acute myocardial infarction in patients with end-stage renal disease: results from the cooperative cardiovascular project.
Chertow GM,
Normand SL, Silva LR, McNeil BJ.
Am J Kidney Dis.
2000;
35
(6):
1044-51
-
Physical activity levels in patients on hemodialysis and healthy sedentary controls.
Johansen KL,
Chertow GM, Ng AV, Mulligan K, Carey S, Schoenfeld PY, Kent-Braun JA.
Kidney Int.
2000;
57
(6):
2564-70
-
Issues in renal nutrition for persons from the former Soviet Union.
Gorodetskaya I,
Matel J, Chertow GM.
J Ren Nutr.
2000;
10
(2):
98-102
-
Vintage, nutritional status, and survival in hemodialysis patients.
Chertow GM,
Johansen KL, Lew N, Lazarus JM, Lowrie EG.
Kidney Int.
2000;
57
(3):
1176-81
-
Hyperparathyroidism and dialysis vintage.
Chertow GM,
Plone M, Dillon MA, Burke SK, Slatopolsky E.
Clin Nephrol.
2000;
54
(4):
295-300
-
Bioelectrical impedance methods in clinical research: a follow-up to the NIH Technology Assessment Conference.
Ellis KJ,
Bell SJ, Chertow GM, Chumlea WC, Knox TA, Kotler DP, Lukaski HC, Schoeller DA.
Nutrition.
1999 Nov-Dec;
15
(11-12):
874-80
-
Metabolic and monetary costs of avoidable parenteral nutrition use.
Trujillo EB,
Young LS, Chertow GM, Randall S, Clemons T, Jacobs DO, Robinson MK.
JPEN J Parenter Enteral Nutr.
1999 Mar-Apr;
23
(2):
109-13
-
Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure.
Weinfeld MS,
Chertow GM, Stevenson LW.
Am Heart J.
1999;
138
(2 Pt 1):
285-90
-
Exploring the reverse J-shaped curve between urea reduction ratio and mortality.
Chertow GM,
Owen WF, Lazarus JM, Lew NL, Lowrie EG.
Kidney Int.
1999;
56
(5):
1872-8
-
Modality-specific nutrition support in ESRD: weighing the evidence.
Chertow GM,
Am J Kidney Dis.
1999;
33
(1):
193-7
-
Estimates of body composition as intermediate outcome variables: are DEXA and BIA ready for prime time?
Chertow GM,
J Ren Nutr.
1999;
9
(3):
138-41
-
A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients.
Chertow GM,
Dillon M, Burke SK, Steg M, Bleyer AJ, Garrett BN, Domoto DT, Wilkes BM, Wombolt DG, Slatopolsky E.
Clin Nephrol.
1999;
51
(1):
18-26
-
Evidence-based organ allocation.
Zenios SA,
Wein LM, Chertow GM.
Am J Med.
1999;
107
(1):
52-61
-
The urea [clearance x dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose.
Lowrie EG,
Chertow GM, Lew NL, Lazarus JM, Owen WF.
Kidney Int.
1999;
56
(2):
729-37
-
Olecranon bursitis caused by infection with Candida lusitaniae.
Behar SM,
Chertow GM.
J Rheumatol.
1998;
25
(3):
598-600
-
Aminoguanidine inhibits advanced glycation end products formation on beta2-microglobulin.
Hou FF,
Boyce J, Chertow GM, Kay J, Owen WF.
J Am Soc Nephrol.
1998;
9
(2):
277-83
-
Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group.
Chertow GM,
Lazarus JM, Paganini EP, Allgren RL, Lafayette RA, Sayegh MH.
J Am Soc Nephrol.
1998;
9
(4):
692-8
-
Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts.
Owen WF,
Hou FF, Stuart RO, Kay J, Boyce J, Chertow GM, Schmidt AM.
Kidney Int.
1998;
53
(5):
1365-73
-
Independent association between acute renal failure and mortality following cardiac surgery.
Chertow GM,
Levy EM, Hammermeister KE, Grover F, Daley J.
Am J Med.
1998;
104
(4):
343-8
-
Haemobilia mimicking acute cholecystitis following percutaneous renal biopsy.
Lee MC,
Jacobs DO, Chertow GM.
Nephrol Dial Transplant.
1998;
13
(8):
2118-20
-
Effects of estrogen replacement therapy on the lipoprotein profile in postmenopausal women with ESRD.
Ginsburg ES,
Walsh B, Greenberg L, Price D, Chertow GM, Owen WF.
Kidney Int.
1998;
54
(4):
1344-50
-
Clearance of Pneumocystis carinii cysts in acute P carinii pneumonia: assessment by serial sputum induction.
O'Donnell WJ,
Pieciak W, Chertow GM, Sanabria J, Lahive KC.
Chest.
1998;
114
(5):
1264-8
-
Cancer screening and detection in patients with end-stage renal disease.
Gornik HL,
Lazarus JM, Chertow GM.
Int J Artif Organs.
1998;
21
(9):
495-500
-
Dialysis: cost-effective "SUPPORT" for patients with acute renal failure.
Chertow GM,
Am J Kidney Dis.
1998;
31
(3):
545-8; discussion 548-9
-
Dose of hemodialysis and survival: differences by race and sex.
Owen WF,
Chertow GM, Lazarus JM, Lowrie EG.
JAMA.
1998;
280
(20):
1764-8
-
Bioimpedance norms for the hemodialysis population.
Chertow GM,
Lazarus JM, Lew NL, Ma L, Lowrie EG.
Kidney Int.
1997;
52
(6):
1617-21
-
Poorer graft survival in African-American transplant recipients cannot be explained by HLA mismatching.
Chertow GM,
Milford EL.
Adv Ren Replace Ther.
1997;
4
(1):
40-5
-
Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure.
Chertow GM,
Burke SK, Lazarus JM, Stenzel KH, Wombolt D, Goldberg D, Bonventre JV, Slatopolsky E.
Am J Kidney Dis.
1997;
29
(1):
66-71
-
Preoperative renal risk stratification.
Chertow GM,
Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, Daley J.
Circulation.
1997;
95
(4):
878-84
-
Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis.
Hou FF,
Chertow GM, Kay J, Boyce J, Lazarus JM, Braatz JA, Owen WF.
Kidney Int.
1997;
51
(5):
1514-9
-
Nephrology.
Chertow GM,
JAMA.
1997;
277
(23):
1872-3
-
Development of a population-specific regression equation to estimate total body water in hemodialysis patients.
Chertow GM,
Lazarus JM, Lew NL, Ma L, Lowrie EG.
Kidney Int.
1997;
51
(5):
1578-82
-
Renal vasculitis with HIV seropositivity: potential manifestation of cytomegalovirus infection.
Chertow GM,
Rennke HG, Curhan GC, Brady HR.
Am J Kidney Dis.
1997;
30
(3):
428-32
-
A practical approach to acute renal failure.
Mindell JA,
Chertow GM.
Med Clin North Am.
1997;
81
(3):
731-48
-
Antigen-independent determinants of graft survival in living-related kidney transplantation.
Chertow GM,
Brenner BM, Mori M, MacKenzie HS, Milford EL.
Kidney Int Suppl.
1997:
63
S84-6
-
On the design and analysis of multicenter trials in acute renal failure.
Chertow GM,
Am J Kidney Dis.
1997;
30
(5 Suppl 4):
S96-101
-
The rise and fall of atrial natriuretic peptide for acute renal failure.
Brenner RM,
Chertow GM.
Curr Opin Nephrol Hypertens.
1997;
6
(5):
474-6
-
Grafts vs fistulas for hemodialysis patients: equal access for all?
Chertow GM,
JAMA.
1996 Oct 23-30;
276
(16):
1343-4
-
Birth weight and adult hypertension and obesity in women.
Curhan GC,
Chertow GM, Willett WC, Spiegelman D, Colditz GA, Manson JE, Speizer FE, Stampfer MJ.
Circulation.
1996;
94
(6):
1310-5
-
Fanconi's syndrome and tubulointerstitial nephritis in association with L-lysine ingestion.
Lo JC,
Chertow GM, Rennke H, Seifter JL.
Am J Kidney Dis.
1996;
28
(4):
614-7
-
Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group.
Chertow GM,
Sayegh MH, Allgren RL, Lazarus JM.
Am J Med.
1996;
101
(1):
49-53
-
"Renal-dose" dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials.
Denton MD,
Chertow GM, Brady HR.
Kidney Int.
1996;
50
(1):
4-14
-
Performance characteristics of a dialysis-related amyloidosis questionnaire.
Chertow GM,
Trimbur T, Karlson EW, Lazarus JM, Kay J.
J Am Soc Nephrol.
1996;
7
(8):
1235-40
-
Restless legs syndrome in end-stage renal disease.
Winkelman JW,
Chertow GM, Lazarus JM.
Am J Kidney Dis.
1996;
28
(3):
372-8
-
Trimethoprim-sulfamethoxazole and hypouricemia.
Chertow GM,
Seifter JL, Christiansen CL, O'Donnell WJ.
Clin Nephrol.
1996;
46
(3):
193-8
-
Antigen-independent determinants of cadaveric kidney transplant failure.
Chertow GM,
Milford EL, Mackenzie HS, Brenner BM.
JAMA.
1996;
276
(21):
1732-6
Help